Activation of Ca(2+)-dependent K+ and Cl- Currents by UTP and ATP in CFPAC-1 Cells
Overview
Affiliations
Activation of Cl- and K+ conductances by nucleotide receptor-operated mobilization of intracellular Ca2+ was investigated in CFPAC-1 cells with the perforated-patch technique. Adenosine 5'-triphosphate (ATP) and uridine 5'-triphosphate (UTP) caused a dose-dependent fast and transient membrane hyperpolarization. UTP was more effective than ATP. In voltage-clamped cells, two currents with different ionic permeability and kinetics were activated by the nucleotides. The first one was carried by Cl- ions, peaked in the first few seconds after addition of nucleotides, and lasted for 1 +/- 0.3 min. Its amplitude was about 2.7 nA at -100 mV with 100 mumol/l of either ATP or UTP. The second current was carried by K+ ions and was blocked by Cs+. This current peaked more slowly and had a mean duration of 4.6 +/- 0.7 min. Its amplitude was 0.9 nA and 0.5 nA at -20 mV with 100 mumol/l UTP and ATP, respectively. Activation of the nucleotide receptor caused a transient increase in intracellular Ca2+ concentration ([Ca2+]i) that was similar in the presence or absence of extracellular Ca2+. The ED50 for UTP was 24 mumol/l and that for ATP was 94 mumol/l. Depletion of the inositol 1,4,5-trisphosphate-sensitive Ca2+ store by thapsigargin prevented both the nucleotide-induced [Ca2+]i increase and the activation of membrane currents. Addition of 2 mmol/l Ca2+ to thapsigargin-treated cells produced a sustained increase of Cl- and K+ currents, which was reversed by Ca2+ removal. The present study demonstrates that CFPAC-1 cells respond to nucleotide receptor activation with a transient increase in [Ca2+]i that stimulates Ca(2+)-dependent Cl- and K+ currents.(ABSTRACT TRUNCATED AT 250 WORDS)
P2 Receptors as Therapeutic Targets in the Salivary Gland: From Physiology to Dysfunction.
Khalafalla M, Woods L, Jasmer K, Munoz Forti K, Camden J, Jensen J Front Pharmacol. 2020; 11:222.
PMID: 32231563 PMC: 7082426. DOI: 10.3389/fphar.2020.00222.
Liu J, Kozakura K, Marcus D Audit Neurosci. 2012; 1(4):331-340.
PMID: 22582019 PMC: 3348583.
Manzanares D, Gonzalez C, Ivonnet P, Chen R, Valencia-Gattas M, Conner G J Biol Chem. 2011; 286(22):19830-9.
PMID: 21454692 PMC: 3103360. DOI: 10.1074/jbc.M110.185074.
Purinergic receptors in the endocrine and exocrine pancreas.
Novak I Purinergic Signal. 2008; 4(3):237-53.
PMID: 18368520 PMC: 2486345. DOI: 10.1007/s11302-007-9087-6.
Interaction of P2 purinergic receptors with cellular macromolecules.
Koles L, Gerevich Z, Oliveira J, Zadori Z, Wirkner K, Illes P Naunyn Schmiedebergs Arch Pharmacol. 2008; 377(1):1-33.
PMID: 18273661 PMC: 7100647. DOI: 10.1007/s00210-007-0222-2.